An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...

New findings from the phase III PRIMARY2 trial presented at EAU26 suggest that PSMA PET/CT imaging after inconclusive or reassuring MRI can safely reduce prostate biopsies by about 50 percent without ...

In elderly patients with suspected prostate cancer, PSMA PET/CT can diagnose advanced disease and aid in therapy selection without the need for a biopsy. Published in the July issue of The Journal of ...

PHILADELPHIA – Fox Chase Cancer Center is the only institution in the Greater Delaware Valley now offering patients the newest in imaging technology called PET/CT scanning. PET/CT is the fusion of two ...

Integrated positron emission tomography/computed tomography (PET/CT) has evolved since its introduction into the commercial market more than a decade ago. It is now a key procedure, particularly in ...

Omni Legend is an innovative, breakthrough technology built from the ground up to harness the power of an advanced digital detector capable of producing high-resolution images and exceptional image ...

Children are more sensitive to radiation than adults. All radiation carries a theoretical risk of inducing cancer. The effective dose to the patient from a typical PET/CT examination may be in the ...

Large retrospective validation study of metabolomic biomarkers for resectable lung cancer detection and risk assessment. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This ...

CHICAGO & BARCELONA, Spain--(BUSINESS WIRE)--At the European Association of Nuclear Medicine (EANM) Annual Meeting, GE Healthcare proudly introduces Omni Legend i, the first system on its all-new, all ...